BDNF and Cognitive impairment: The systemic administration or intrahippocampal microinjection of anti-proBDNF antibodies (mAb-proB) attenuated cognitive impairment, which may be due to the expansion of neuronal function and the synaptic transmission-associated protein level of the hippocampus in SAE progression.